S&P BSE 150 Midcap Index News and Updates

Name: Latest research reports of Apollo Tyres Ltd. authored by ICICI Direct and published by - Trendlyne research reports.
Item: Apollo Tyres Ltd.
Rating: 5
Author: ICICI Direct

Keep track of all breaking news on S&P BSE 150 Midcap Index from all sources in a single place.

Cochin Shipyard Ltd.

16 Nov 2025, 06:51PM

1725.30

1.05%

Navy to commission indigenous anti-submarine warfare vessel on Nov 24

Business Standard

Anti-submarine warfare shallow-water craft 'Mahe', equipped with torpedoes, multi-functional anti-submarine rockets and advanced radars and sonars, is set to be commissioned into the Indian Navy on November 24, officials said on Sunday. The first of the eight Anti-submarine warfare shallow water craft (ASW SWC) being built by the Cochin Shipyard Limited (CSL) is named after Mahe, the historic port town in Puducherry, and symbolises India's rich maritime heritage. With her blend of firepower, stealth and mobility, the ship is designed to hunt submarines, conduct coastal patrols, and secure India's vital maritime approaches, a Navy spokesperson said. Equipped with torpedoes and anti-submarine rockets, the first of the Mahe-class ASW-SWC was delivered to the Navy on October 23. The Navy is poised to script another milestone in its indigenous shipbuilding journey with the commissioning of 'Mahe' at the Naval Dockyard in Mumbai on November 24, the spokesperson said. 'Mahe' represents t

Cochin Shipyard Ltd. is trading below its 30 day SMA of 1788.2

Godrej Properties Ltd.

16 Nov 2025, 02:55PM

2195.80

-0.47%

Godrej Properties To Launch Properties Worth Rs 22,000 Crore For Sale In H2 FY26

NDTV Profit

Godrej Properties pre-sales grew 13 per cent to Rs 15,587 crore in the first six months of this fiscal from Rs 13,835 crore in the year-ago period.

ICICI Securities Limited released a Buy report for Godrej Properties Ltd. with a price target of 2603.0 on 06 Nov, 2025.

Godrej Properties set to launch properties worth 22,000-cr for sale in H2 FY26

Business Line | 16 Nov 2025, 02:52PM 1 more

Indraprastha Gas Ltd.

16 Nov 2025, 01:16PM

212.66

-1.10%

CNG Price Hike: IGL Raises Gas Prices By Rs 1/Kg In Noida, Other Cities From Mov 16Check New Rates

NDTV Profit

CNG Price Hike: IGL said the the new rates came into effect from 6:00 am on Nov. 16, 2025. The hike averages Rs 1 per kg across Noida, Greater Noida, Ghaziabad, and Kanpur.

Number of FII/FPI investors increased from 337 to 343 in Sep 2025 qtr.

Apollo Tyres Ltd.

16 Nov 2025, 12:00AM

518.70

-3.39%

Apollo Tyres

Buy: Apollo Tyres Ltd.

Target

ICICI Direct

About the stock: Apollo Tyres (ATL), is a leading tyre manufacturer, having operations in India & Europe. In India, ATL has substantial presence in TBR (~30% market share) and PCR space (~20% market share). India contributes ~67% of sales Q2FY26 Results: ATL reported healthy performance in Q2'26. Revenues on consolidated basis in Q2FY26 stood at 6,831 crores, up 6% YoY. EBITDA for the quarter stood at 1,021 crore with EBITDA margins at 14.9%, up ~170 bps QoQ. Consequent PAT for Q2FY26 came in at 258 crores, down 13% on YoY basis (include one-time exceptional charge on account of closure of Netherland plant)....

Number of FII/FPI investors increased from 302 to 313 in Sep 2025 qtr.

Ashok Leyland Ltd.

16 Nov 2025, 12:00AM

148.26

-1.43%

Ashok Leyland

Hold: Ashok Leyland Ltd.

ICICI Direct

About the stock: Ashok Leyland (ALL) is a pure-play CV manufacturer FY25 product mix LCV goods 35%, trucks 50%, buses 15% Q2FY26 Results: Company reported healthy operational performance in Q2'26. Standalone revenues for Q2FY26 came in at 9,588 crore, up 9.3% YoY amidst 8% growth in volumes to 49k units. EBITDA for the quarter came in at 1,162 crore with margins at 12.1%, up 100 bps QoQ. Consequent PAT in Q2FY26 came in at ...

ICICI Direct released a Hold report for Ashok Leyland Ltd. with a price target of 165.0 on 16 Nov, 2025.

IRB Infrastructure Developers Ltd.

15 Nov 2025, 03:06PM

42.96

1.44%

IRB Infrastructure Trust bags TOT project from NHAI in UP for upfront 9,270 cr

Business Line

IRB Infrastructure Trust is the private InvIT (infrastructure investment trust) sponsored by IRB Infrastructure Developers.

IRB Infrastructure Developers Ltd. is trading below all available SMAs

IRB Infrastructure Trust secures UP highway project for 9,270 crore

Business Standard | 15 Nov 2025, 01:47PM

Swiggy Ltd.

15 Nov 2025, 11:46AM

393.10

2.61%

Food delivery set for 2022% GOV growth; Eternal & Swiggy top bets

Economic Times

India's food delivery and quick commerce sectors are heading into a renewed competitive phase as firms boost promotions and spending. Despite rising discounting, stronger unit economics, disciplined expansion, higher throughput, and improving profitability support a stable medium-term growth outlook.

Swiggy Ltd. is trading above its 200 day SMA of 381.8

Hero MotoCorp Ltd.

15 Nov 2025, 11:03AM

5538.50

0.54%

Hero MotoCorp Shares 'Attractively Valued' At Current Levels Says Motilal Oswal; Rates Stock A 'Buy'

NDTV Profit

Motilal Oswal maintains 'Buy' rating on Hero MotoCorp post steady Q2 numbers; sees 17% upside - Check details

Hero MotoCorp Ltd. is trading above all available SMAs

Glenmark Pharmaceuticals Ltd.

14 Nov 2025

1895.60

0.80%

Glenmark Pharmaceuticals Q2 results: Profit jumps 72% to 610.43 cr

Business Standard

Glenmark Pharmaceuticals Ltd on Friday reported a 72.2 per cent jump in consolidated profit after tax at Rs 610.43 crore in the second quarter ended September 2025 on the back of its licensing deal with AbbVie for investigational asset 'ISB 2001'. The company had posted a consolidated profit after tax (PAT) of Rs 354.49 crore in the corresponding period last fiscal, Glenmark Pharmaceuticals Ltd said in a regulatory filing. Consolidated total revenue from operations was at Rs 6,046.87 crore as against Rs 3,433.8 crore in the same period a year ago, it added. Total expenses in the quarter under review were at Rs 3,894.98 crore as against Rs 3,000.64 crore in the same period last fiscal, the company said. "Q2FY26 reflects the steady progress we are making in strengthening Glenmark's scientific and strategic foundation. The AbbVie partnership for ISB 2001, along with the income recognised this quarter, is a significant validation of our scientific strength and enables us to advance the